Evidence of a Role for the Q151L Mutation and the Viral Background in Development of Multiple Dideoxynucleoside-Resistant Human Immunodeficiency Virus Type 1

The majority of human immunodeficiency virus type 1 (HIV-1)-infected patients treated with zidovudine (AZT) plus zalcitabine (ddC) and didanosine (ddI) develop AZT resistance mediated by mutations such as T215Y and M41L. Only a small proportion of patients develop multiple dideoxynucleoside resistan...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Virol
Egile Nagusiak:	García-Lerma, J. Gerardo, Gerrish, Philip J., Wright, Anthony C., Qari, Shoukat H., Heneine, Walid
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2000
Gaiak:	Vaccines and Antiviral Agents
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112361/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11000201/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.20.9339-9346.2000
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!